GENOME ANNOUNCEMENT {#h0.0}
===================

The emergence and spread of antimicrobial resistance in *Neisseria gonorrhoeae* requires a deeper knowledge of the genetic basis of resistance. The use of genomes for surveillance purposes could be considered a useful strategy to improve public health microbiology ([@B1]).

We announce the draft genome sequence of *N. gonorrhoeae* G2891, collected in 2013 from a heterosexual man of 50 years with urethritis. The isolate was resistant to cefixime (MIC, 0.19 mg/liter), ciprofloxacin (MIC, 32 mg/liter), and azithromycin (MIC, 1.5 mg/liter).

The isolate belonged to ST1407 according to *Neisseria gonorrhoeae* multi-antigen sequence typing (NG-MAST); this sequence type, together with closely related sequence types, defines the genogroup (G) 1407, which is mainly associated with resistance to extended-spectrum cephalosporins ([@B2], [@B3]).

DNA was extracted using the QiAmp minikit (Qiagen, Hilden, Germany) from an overnight culture grown on a Thayer Martin plus 1% IsoVitalex (Oxoid, Hampshire, United Kingdom) agar plate at 37°C. Antimicrobial susceptibility was obtained by *E* test (bioMérieux, Sweden) according to the manufacturer's instructions. The clinical breakpoints were those indicated by the European Committee on Antimicrobial Susceptibility testing (EUCAST, version 5.0, 2015) ([@B4]).

The *porB* and *tbpB* alleles were assigned at the NG-MAST website (<http://www.ng-mast.net>). Whole-genome sequencing was performed using both the MiSeq and the NextSeq 500 Illumina platforms. The MiSeq run generated 2,451,407 paired-end reads (300 × 2 bp), while the NextSeq 500 produced 4,078,929 paired-end reads (150 × 2 bp). Reads were trimmed to keep high-quality bases (*Q* score \>25): 2,113,645 and 2,796,663 paired-end reads, respectively, were further analyzed (coverage \~600×). For both sets of reads, *de novo* assembly was performed using ABySS version 1.3.5 ([@B5]) and Velvet version 1.2.10 ([@B6]). To improve the contiguity and the accuracy of the assembly, contigs resulting from different analysis were integrated with CISA ([@B7]). The final assembly was composed of 132 contigs (\>500 nucleotides), and the draft genome sequence was 2,149,953 bp long.

The 132 contigs were submitted to the NCBI whole-genome shotgun (WGS) submission portal (<https://submit.ncbi.nlm.nih.gov/subs/wgs>), and the sequence was annotated using the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) (<http://www.ncbi.nlm.nih.gov/genome/annotation_prok>).

Of note, *N. gonorrhoeae* G2891 shared the *penA* mosaic allele XXXIV (GenBank accession number GU723422.1); this *penA* allele was described for the first time in San Francisco in 2008 ([@B8]) and has been commonly associated with cefixime resistance ([@B9]). Moreover, the deletion A in the promoter region and the amino acid substitution H105Y in the *mtrR* gene, the amino acid substitution L421P in the *ponA* gene, and the amino acid substitutions G120K and A121N in the *porB1b* gene were identified. By multilocus sequence typing (MLST), the isolate belonged to ST1901.

Nucleotide sequence accession number. {#s1}
-------------------------------------

This whole-genome shotgun project has been deposited in DDBJ/GenBank under the accession number [LDOB00000000](LDOB00000000)**.**
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